CA2317530A1 - Dysuria remedies - Google Patents

Dysuria remedies Download PDF

Info

Publication number
CA2317530A1
CA2317530A1 CA002317530A CA2317530A CA2317530A1 CA 2317530 A1 CA2317530 A1 CA 2317530A1 CA 002317530 A CA002317530 A CA 002317530A CA 2317530 A CA2317530 A CA 2317530A CA 2317530 A1 CA2317530 A1 CA 2317530A1
Authority
CA
Canada
Prior art keywords
dysuria
remedies
urinary tract
lower urinary
tract diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002317530A
Other languages
French (fr)
Other versions
CA2317530C (en
Inventor
Tamio Yamauchi
Tomohiro Ueda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2317530A1 publication Critical patent/CA2317530A1/en
Application granted granted Critical
Publication of CA2317530C publication Critical patent/CA2317530C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Remedies for dysuria and lower urinary tract diseases, containing as the active ingredient [2-[4-(3-ethoxy-2-hydroxypropoxy)phenylcarbamoyl)-ethyl]dimethylsulfonium salts of organic acids. These remedies enable the treatment of lower urinary tract diseases causative of dysuria, e.g., interstitial cystitis and prostatitis which have not yet been elucidated in the cause and have been believed to be intractable.
CA002317530A 1998-11-05 1999-11-05 Dysuria remedies Expired - Fee Related CA2317530C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP10/314369 1998-11-05
JP31436998 1998-11-05
JP11/39779 1999-02-18
JP3977999 1999-02-18
PCT/JP1999/006170 WO2000027383A1 (en) 1998-11-05 1999-11-05 Dysuria remedies

Publications (2)

Publication Number Publication Date
CA2317530A1 true CA2317530A1 (en) 2000-05-18
CA2317530C CA2317530C (en) 2004-04-27

Family

ID=26379168

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002317530A Expired - Fee Related CA2317530C (en) 1998-11-05 1999-11-05 Dysuria remedies

Country Status (10)

Country Link
US (1) US6329428B1 (en)
EP (1) EP1055426B1 (en)
JP (1) JP3507439B2 (en)
KR (1) KR100375003B1 (en)
CN (1) CN1224384C (en)
AT (1) ATE413869T1 (en)
AU (1) AU734793B2 (en)
CA (1) CA2317530C (en)
DE (1) DE69939894D1 (en)
WO (1) WO2000027383A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1295870B1 (en) * 2001-04-16 2007-12-19 Taiho Pharmaceutical Company Limited Suplatast tosilate crystals
ES2359719T3 (en) * 2001-07-10 2011-05-26 Astellas Pharma Inc. PHARMACEUTICAL COMPOSITION UNDERSTANDING QUINUCLIDIN-3'-IL 1-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLIN-2-CARBOXYLATE FOR THE TREATMENT OF INSTERSTICIAL CYSTITIS AND / OR NON-BACTERIAL PROSTATITIS.
JP3921664B2 (en) * 2002-10-29 2007-05-30 大鵬薬品工業株式会社 Non-bacterial prostatitis model animal
JP4794148B2 (en) * 2004-09-10 2011-10-19 大鵬薬品工業株式会社 Nephrotic syndrome therapeutic agent
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
CA2613030C (en) 2005-06-27 2011-03-15 Juntendo Educational Foundation Agent for the treatment of herpes virus-derived pain
WO2008078826A1 (en) * 2006-12-26 2008-07-03 Taiho Pharmaceutical Co., Ltd. Therapeutic agent for diabetic neuropathy
WO2008100997A2 (en) * 2007-02-14 2008-08-21 Prelief Inc. Methods for treating or preventing hemorrhagic cystitis using a glycerophosphate salt
US7902260B2 (en) * 2007-02-28 2011-03-08 Kemphys Ltd. Medicament for preventive and/or therapeutic treatment of lower urinary tract symptom
US20080275015A1 (en) * 2007-05-01 2008-11-06 Potter Jeffrey A Formulation and Method for Treating Interstitial Cystitis and Related Bladder Conditions
US20100210600A1 (en) * 2009-02-19 2010-08-19 Prelief Inc. Methods and Compositions for Treating Urogenital Disorders
JPWO2011065444A1 (en) 2009-11-27 2013-04-18 学校法人東海大学 Antithrombotic
JP6894555B1 (en) * 2020-07-03 2021-06-30 大鵬薬品工業株式会社 Urinary symptom therapeutic agent
JP2022013721A (en) * 2020-07-03 2022-01-18 大鵬薬品工業株式会社 Urinary symptom therapeutic agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556737A (en) * 1983-03-11 1985-12-03 Taiho Pharmaceutical Company Limited Sulfonium compounds, processes for preparing the compounds and pharmacological composiitons containing the same
GB2274241B (en) * 1993-01-19 1996-06-05 Rack Eng Improvements relating to pull-out shelf support systems
TW264385B (en) * 1993-05-14 1995-12-01 Taiho Pharmaceutical Co Ltd
WO1996033741A1 (en) * 1995-04-24 1996-10-31 Taiho Pharmaceutical Co., Ltd. Remedy for allergic diseases in the region of the nose

Also Published As

Publication number Publication date
CN1224384C (en) 2005-10-26
KR20010033852A (en) 2001-04-25
AU734793B2 (en) 2001-06-21
EP1055426A1 (en) 2000-11-29
JP3507439B2 (en) 2004-03-15
CN1287485A (en) 2001-03-14
AU1077900A (en) 2000-05-29
US6329428B1 (en) 2001-12-11
EP1055426B1 (en) 2008-11-12
DE69939894D1 (en) 2008-12-24
KR100375003B1 (en) 2003-03-06
CA2317530C (en) 2004-04-27
EP1055426A4 (en) 2005-04-06
ATE413869T1 (en) 2008-11-15
WO2000027383A1 (en) 2000-05-18

Similar Documents

Publication Publication Date Title
CA2317530A1 (en) Dysuria remedies
WO1998033490A3 (en) Use of percaboxylic acids in the control of hairy wart disease
EP1690536A3 (en) Use of r-(+)-2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxy-methyl-phenylisobutyric acid ester hydrogenfumarate for the treatment of urinary incontinence and other spasmogenic disorders
AU4322297A (en) 1,2,3-thiadiazole derivatives and salts thereof, disease controlling agents for agricultural and horticultural use, and method for the use thereof
CA2310207A1 (en) Topical zinc compositions and methods of use
JP2002510602A5 (en)
WO2002053101A3 (en) Method for treating fibrotic diseases or other indications
AU764280C (en) Process for the preparation of pellets with a content of up to 90 wt. per cent of a pharmaceutical active ingredient
WO1996015784A3 (en) 2,2-dichloroalkane carboxylic acids, process for preparing the same, medicament containing the same, and use thereof for treating insulin resistance
DE69932939D1 (en) FULVIC ACID AND ITS USE FOR THE TREATMENT OF VARIOUS DISEASE STATES
ES2142205A1 (en) New liq. insecticidal prepn. for heat fumigation
CA2313878A1 (en) Composition for suppressing behavior problems of pets
CA2386406A1 (en) Tissue products containing antiviral agents which are mild to the skin
CA2368165A1 (en) Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
WO2001010427A3 (en) Use of anti-muscarinic agents for treating skin disorders
EP1284265A4 (en) Benzothiophene derivatives and medicinal use thereof
WO2003055559A8 (en) Dialkyl-substituted acetic acid and glyceric acid based active substance combinations against bacteria, mycota and viruses
EP1342410A3 (en) Transgenic animals lacking a functional galanin gene
AU5780398A (en) Pharmaceutical composition for treatment of heart disease based on cardiac hypertrophy
JP2004537546A5 (en)
NO20013544L (en) Means for treating Parkinson's disease and its use
AU4937699A (en) Use of succinic acid or salts thereof for the treatment of diabetes mellitus andwound healing
RU94011321A (en) METHOD OF PREVENTION AND TREATMENT OF SKIN DISEASES
NO20013605L (en) Preparation for warts
EP1238652A4 (en) Compositions for peeling

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20161107